Related references
Note: Only part of the references are listed.Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
Nicola Relitti et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations
Masashi Fujita et al.
EBIOMEDICINE (2020)
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
David Esopi et al.
CELLULAR ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Telomerase reverse transcriptase (TERT) promoter mutation correlated with intratumoral heterogeneity in hepatocellular carcinoma
Wit Thun Kwa et al.
PATHOLOGY INTERNATIONAL (2020)
HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines
Sung Hoon Choi et al.
JOURNAL OF CANCER (2020)
Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma
Nancy M. Joseph et al.
JOURNAL OF PATHOLOGY (2019)
Keratin 19-expressing hepatocellular carcinoma and small-duct type intrahepatic cholangiocarcinoma show a similar postoperative clinical course but have distinct genetic features
Masayuki Akita et al.
HISTOPATHOLOGY (2019)
DNA hypermethylation within TERT promoter upregulates TERT expression in cancer (vol 129, pg 223, 2019)
Donghyun D. Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach
Keun Soo Ahn et al.
HEPATOLOGY INTERNATIONAL (2019)
Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum
Nancy M. Joseph et al.
MODERN PATHOLOGY (2019)
The role of telomeres and telomerase in cirrhosis and liver cancer
Jean-Charles Nault et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma
Masataka Amisaki et al.
CANCER SCIENCE (2019)
BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits
Xinrui Zhao et al.
REDOX BIOLOGY (2019)
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma
Jingya Yu et al.
CANCER LETTERS (2018)
Phenotypic and molecular changes in nodule-in-nodule hepatocellular carcinoma with pathogenetic implications
Noemi Rudini et al.
HISTOPATHOLOGY (2018)
Distinction of intrahepatic metastasis from multi centric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations
Peter Chianchiano et al.
HUMAN PATHOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis
Cagatay Guenes et al.
NATURE REVIEWS UROLOGY (2018)
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features
Xiangchun Li et al.
THERANOSTICS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice
Lole Ferrara-Romeo et al.
PLOS ONE (2018)
Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance
Motoko Sasaki et al.
HISTOPATHOLOGY (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
Hye Won Lee et al.
MEDICINE (2017)
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Floris P. Barthel et al.
NATURE GENETICS (2017)
Identification of liver-specific enhancer-promoter activity in the 3′ untranslated region of the wild-type AAV2 genome
Grant J. Logan et al.
NATURE GENETICS (2017)
Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism
Kunitoshi Chiba et al.
SCIENCE (2017)
Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma
Wan Huang et al.
ONCOTARGET (2017)
The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma
Xiaotian Yuan et al.
ONCOTARGET (2017)
RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma
Tianze Liu et al.
THERANOSTICS (2017)
Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes
Josh Lewis Stern et al.
CELL REPORTS (2017)
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
Benedetta Donati et al.
CANCER MEDICINE (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
Agrin Moeini et al.
CLINICAL CANCER RESEARCH (2016)
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features
Fukiko Kawai-Kitahata et al.
JOURNAL OF GASTROENTEROLOGY (2016)
The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer
Eunkyong Ko et al.
ONCOTARGET (2016)
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Andrea Marengo et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma
Ruidong Xue et al.
GASTROENTEROLOGY (2016)
Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis
Yingcheng Yang et al.
GUT (2016)
TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma
Soo Ki Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
Daniel Dauch et al.
NATURE MEDICINE (2016)
Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
Ling-Hao Zhao et al.
NATURE COMMUNICATIONS (2016)
TERT promoter mutations in primary liver tumors
Jean-Charles Nault et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma
Seung Eun Lee et al.
ONCOTARGET (2016)
Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma
Francesca Pezzuto et al.
ONCOTARGET (2016)
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma
Xunjun Yang et al.
ONCOTARGET (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
Dong-Sheng Huang et al.
EUROPEAN JOURNAL OF CANCER (2015)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Linda J. Valentijn et al.
NATURE GENETICS (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Jean-Charles Nault et al.
NATURE GENETICS (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
TERT promoter mutations and telomerase reactivation in urothelial cancer
Sumit Borah et al.
SCIENCE (2015)
Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations
Dilek Cevik et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
Akihiro Fujimoto et al.
NATURE COMMUNICATIONS (2015)
Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population
Hong Zhang et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Molecular diagnosis of intrahepatic cholangiocarcinoma
Hiroaki Haga et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
Matthias Simon et al.
NEURO-ONCOLOGY (2015)
Pathogenesis of hepatocellular carcinoma according to aetiology
Jean-Charles Nault
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb F. Davis et al.
CANCER CELL (2014)
Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation
Camilla Pilati et al.
CANCER CELL (2014)
Changing Pattern of Epidemiology in Intrahepatic Cholangiocarcinoma
Basile Njei
HEPATOLOGY (2014)
Telomerase Reverse Transcriptase Promoter Mutation Is an Early Somatic Genetic Alteration in the Transformation of Premalignant Nodules in Hepatocellular Carcinoma on Cirrhosis
Jean Charles Nault et al.
HEPATOLOGY (2014)
TERT promoter mutations: Gatekeeper and driver of hepatocellular carcinoma
Roser Pinyol et al.
JOURNAL OF HEPATOLOGY (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Yasushi Totoki et al.
NATURE GENETICS (2014)
Frequency of TERT promoter mutations in primary tumors of the liver
Alexander Quaas et al.
VIRCHOWS ARCHIV (2014)
TERT promoter mutation in resectable hepatocellular carcinomas: A strong association with hepatitis C infection and absence of hepatitis B infection
Yu-Ling Chen et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
The Role of Telomeres in Stem Cells and Cancer
Cagatay Guenes et al.
CELL (2013)
CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis
Mukesh Kumar et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
Inigo Landa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Landscape of DNA Virus Associations across Human Malignant Cancers: Analysis of 3,775 Cases Using RNA-Seq
Joseph D. Khoury et al.
JOURNAL OF VIROLOGY (2013)
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
P. Sivaramakrishna Rachakonda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
Jean Charles Nault et al.
NATURE COMMUNICATIONS (2013)
Telomere-Driven Tetraploidization Occurs in Human Cells Undergoing Crisis and Promotes Transformation of Mouse Cells
Teresa Davoli et al.
CANCER CELL (2012)
Telomere dysfunction puts the brakes on oncogene-induced cancers
Cagatay Guenes et al.
EMBO JOURNAL (2012)
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions
Anitha Suram et al.
EMBO JOURNAL (2012)
Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver
Suman Verma et al.
HEPATOLOGY (2012)
Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis
Yvonne Begus-Nahrmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Wing-Kin Sung et al.
NATURE GENETICS (2012)
Progressive Telomere Dysfunction Causes Cytokinesis Failure and Leads to the Accumulation of Polyploid Cells
Judit Pampalona et al.
PLOS GENETICS (2012)
The Promoter of Human Telomerase Reverse Transcriptase Is Activated During Liver Regeneration and Hepatocyte Proliferation
Hueseyin Sirma et al.
GASTROENTEROLOGY (2011)
Constitutional Telomerase Mutations Are Genetic Risk Factors for Cirrhosis
Rodrigo T. Calado et al.
HEPATOLOGY (2011)
Telomerase Gene Mutations Are Associated with Cirrhosis Formation
Daniel Hartmann et al.
HEPATOLOGY (2011)
Persistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy
Teresa Davoli et al.
CELL (2010)
Whole Chromosome Loss Is Promoted by Telomere Dysfunction in Primary Cells
Judit Pampalona et al.
GENES CHROMOSOMES & CANCER (2010)
Defining the Pathogenic Role of Telomerase Mutations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Michael Kirwan et al.
HUMAN MUTATION (2009)
Epidemiology of hepatocellular carcinoma in Japan
Takeji Umemura et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
Rodrigo T. Calado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence
Motoko Sasaki et al.
HEPATOLOGY (2008)
Hepatitis C Virus NS5A Protein Down-regulates the Expression of Spindle Gene Aspm through PKR-p38 Signaling Pathway
Shun-Chi Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Amplification of c-myc and cyclin D1 genes in primary and metastatic carcinomas of the liver
Yoshihisa Takahashi et al.
PATHOLOGY INTERNATIONAL (2007)
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Kalliopi D. Tsakiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease
Andre Lechel et al.
GASTROENTEROLOGY (2007)
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis
Ruben Raphael Plentz et al.
HEPATOLOGY (2007)
Telomerase mutations in families with idiopathic pulmonary fibrosis
Mary Y. Armanios et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma
Donna E. Hansel et al.
MODERN PATHOLOGY (2006)
Differential cis-regulation of human versus mouse TERT gene expression in vivo: Identification of a human-specific repressive element
L Horikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Shelterin: the protein complex that shapes and safeguards human telomeres
T de Lange
GENES & DEVELOPMENT (2005)
Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma
RR Plentz et al.
HEPATOLOGY (2005)
hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer
R Palmqvist et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia
H Yamaguchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage
SU Wiemann et al.
ONCOGENE (2005)
A novel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues
JM Ritz et al.
CANCER RESEARCH (2005)
Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma
RR Plentz et al.
HEPATOLOGY (2004)
Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma
Y Takuma et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA
PF Fogarty et al.
LANCET (2003)
Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells
A Satyanarayana et al.
EMBO JOURNAL (2003)
Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene
P Paterlini-Bréchot et al.
ONCOGENE (2003)
HTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors
X Fan et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The molecular physiology of liver regeneration following partial hepatectomy
D Mangnall et al.
LIVER INTERNATIONAL (2003)
Hepatocellular carcinoma - An epidemiologic view
HB El-Serag
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity
I Guilleret et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
SU Wiemann et al.
FASEB JOURNAL (2002)
The histone deacetylase inhibitor trichostatin a derepresses the telomerase reverse transcriptase (hTERT) gene in human cells
M Hou et al.
EXPERIMENTAL CELL RESEARCH (2002)
Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers
V Kotoula et al.
LIVER (2002)
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
T Vulliamy et al.
NATURE (2001)
In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis
N Youssef et al.
JOURNAL OF PATHOLOGY (2001)
Telomerase activation by histone deacetylase inhibitor in normal cells
M Takakura et al.
NUCLEIC ACIDS RESEARCH (2001)
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells
DW Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas
V Paradis et al.
HUMAN PATHOLOGY (2001)
Wild-derived inbred mouse strains have short telomeres
MT Hemann et al.
NUCLEIC ACIDS RESEARCH (2000)
Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery
KL Rudolph et al.
SCIENCE (2000)
Share Paper
